本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kura Oncology, Inc

8.48
+0.17002.05%
成交量:206.66萬
成交額:1,736.43萬
市值:7.38億
市盈率:-3.42
高:8.56
開:8.28
低:8.25
收:8.31
52周最高:12.49
52周最低:5.41
股本:8,701.75萬
流通股本:6,398.56萬
量比:1.51
換手率:3.23%
股息:- -
股息率:- -
每股收益(TTM):-2.4801
每股收益(LYR):-2.0193
淨資產收益率:-65.10%
總資產收益率:-26.57%
市淨率:3.04
市盈率(LYR):-4.20

資料載入中...

2026/01/29

重要事件披露

Form 8-K - Current report
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

重要事件披露

Form 8-K - Current report
2025/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

重要事件披露

Form 8-K - Current report
2025/11/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/04

重要事件披露

Form 8-K - Current report